Feedback / Questions
MEDI 5117 - WuXi AppTec, AstraZeneca
AstraZeneca: Pipeline update
(AstraZeneca Press Release)
-
Jan 15, 2014 -
Discontinuation of MEDI5117 for OA pain due to safety/efficacy reasons.
Discontinued
•
Immunology
http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DDevelopment-pipeline-table.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285664659458&ssbinary=true
Jan 15, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.